Hepatitis Monthly

Published by: Kowsar

Comparative Proteomics of Sera From HCC Patients With Different Origins

Jamal Sarvari 1 , Zahra Mojtahedi 2 , Yasuhiro Kuramitsu 3 , Mohammad Reza Fattahi 4 , Abbas Ghaderi 2 , Kazuyuki Nakamura 3 and Nasrollah Erfani 2 , *
Authors Information
1 Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
4 Department of Internal Medicine, School of Medicine, Shiraz University of Medical sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: January 01, 2014, 14 (1); e13103
  • Published Online: January 19, 2014
  • Article Type: Research Article
  • Received: June 23, 2013
  • Revised: September 28, 2013
  • Accepted: October 29, 2013
  • DOI: 10.5812/hepatmon.13103

To Cite: Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi M R, Ghaderi A, et al. Comparative Proteomics of Sera From HCC Patients With Different Origins, Hepat Mon. 2014 ; 14(1):e13103. doi: 10.5812/hepatmon.13103.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Blum HE. Hepatocellular carcinoma. Hepat Mon. 2011; 2(11): 69-70
  • 2. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010; 7(8): 448-58[PubMed]
  • 3. Kuramitsu Y, Nakamura K. Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics. 2006; 6(20): 5650-61[DOI][PubMed]
  • 4. Darvish Moghaddam S, Haghdoost AA, Hoseini SH, Ramazani R, Rezazadeh kermani M. Incidence of Hepatocellular Carcinoma in Southeast Iran. Hepat Mon. 2010; 4(10): 270-274
  • 5. Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. - Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend. - Asian Pac J Cancer Prev. 2010;11(4):859-62.
  • 6. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000; (3): 192-201
  • 7. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, et al. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics. 2006; 6(13): 3894-900[DOI][PubMed]
  • 8. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994; 20(1): 65-71[PubMed]
  • 9. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010; 29(16): 2309-24[DOI][PubMed]
  • 10. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002; 31(4): 339-46[DOI][PubMed]
  • 11. Sarvari J, Mojtahedi Z, Kuramitsu Y, Malekhosini SA, Shamsi Sharabadi M, Ghderi A, et al. Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection. Oncology Letter. 2011; 2(5): 871-877
  • 12. Sarvari J, Mojtahedi Z, Taghavi SAR, Kuramitsu Y, Shamsi Shahrabadi M, Ghaderi A, et al. Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison with HBV Infection: A proteomics study. Hepat Mon. 2013; 13(7)
  • 13. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis. 2000; 21(17): 3666-72[PubMed]
  • 14. Kim W, Oe Lim S, Kim JS, Ryu YH, Byeon JY, Kim HJ, et al. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res. 2003; 9(15): 5493-500[PubMed]
  • 15. Haupt H, Baudner S. [Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl)]. Hoppe Seylers Z Physiol Chem. 1977; 358(6): 639-46[PubMed]
  • 16. Andersen JD, Boylan KL, Xue FS, Anderson LB, Witthuhn BA, Markowski TW, et al. Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis. Electrophoresis. 2010; 31(4): 599-610[DOI][PubMed]
  • 17. Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun. 2009; 382(4): 776-9[DOI][PubMed]
  • 18. Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, et al. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol. 1997; 27(2): 67-70[PubMed]
  • 19. Fleming CE, Nunes AF, Sousa MM. Transthyretin: more than meets the eye. Prog Neurobiol. 2009; 89(3): 266-76[DOI][PubMed]
  • 20. Albuquerque LM, Trugilho MR, Chapeaurouge A, Jurgilas PB, Bozza PT, Bozza FA, et al. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res. 2009; 8(12): 5431-41[DOI][PubMed]
  • 21. Borish L, King MS, Mascali JJ, Johnson S, Coll B, Rosenwasser LJ. Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation. 1992; 16(5): 471-84[PubMed]
  • 22. Quaye IK. Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg. 2008; 102(8): 735-42[DOI][PubMed]
  • 23. Zhang Z, Bast RC, Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004; 64(16): 5882-90[DOI][PubMed]
  • 24. Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A. 2006; 103(6): 1828-33[DOI][PubMed]
  • 25. Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology. 2005; 209(9): 689-97[PubMed]
  • 26. Okano T, Kondo T, Kakisaka T, Fujii K, Yamada M, Kato H, et al. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics. 2006; 6(13): 3938-48[PubMed]
  • 27. Greco M, Mitri MD, Chiriaco F, Leo G, Brienza E, Maffia M. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett. 2009; 283(2): 222-9[PubMed]
  • 28. Ahmed N, Barker G, Oliva KT, Hoffmann P, Riley C, Reeve S, et al. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer. 2004; 91(1): 129-40[PubMed]
  • 29. Yu HR, Kuo HC, Sheen JM, Wang L, Lin IC, Wang CL, et al. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol. 2009; 20(7): 699-707[DOI][PubMed]
  • 30. Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer. 1989; 64(10): 2117-20[PubMed]
  • 31. Ang IL, Poon TC, Lai PB, Chan AT, Ngai SM, Hui AY, et al. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res. 2006; 5(10): 2691-700[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments